Lantern Pharma
LTRN
$6.15
Share price
12.02%
Change (1 day)
22.75%
Change (1 year)
Categories
Lantern Pharma (LTRN) - Cash on Hand
Cash on Hand as of December 2023 : $41.3 M
According to Lantern Pharma's latest financial reports the company has $41.3 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Lantern Pharma - Cash on Hand chart (from 2019 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $55.19 M | -21.96% |
| 2021-12-31 | $70.72 M | 267.8% |
| 2020-12-31 | $19.22 M | 1460.78% |
| 2019-12-31 | $1.23 M | 176.76% |
| 2018-12-31 | $0.44 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.20 B | 404.05% | 🇺🇸 USA |